These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28285878)

  • 1. Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells.
    Blum W; Pecze L; Felley-Bosco E; Wu L; de Perrot M; Schwaller B
    Stem Cell Reports; 2017 Apr; 8(4):1005-1017. PubMed ID: 28285878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.
    Shapiro IM; Kolev VN; Vidal CM; Kadariya Y; Ring JE; Wright Q; Weaver DT; Menges C; Padval M; McClatchey AI; Xu Q; Testa JR; Pachter JA
    Sci Transl Med; 2014 May; 6(237):237ra68. PubMed ID: 24848258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Calretinin Expression in Human Mesothelioma Cells Reveals the Implication of the FAK and Wnt Signaling Pathways in Conferring Chemoresistance towards Cisplatin.
    Wörthmüller J; Salicio V; Oberson A; Blum W; Schwaller B
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells.
    Pattarozzi A; Carra E; Favoni RE; Würth R; Marubbi D; Filiberti RA; Mutti L; Florio T; Barbieri F; Daga A
    Stem Cell Res Ther; 2017 May; 8(1):119. PubMed ID: 28545562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed.
    Cortes-Dericks L; Carboni GL; Schmid RA; Karoubi G
    Int J Oncol; 2010 Aug; 37(2):437-44. PubMed ID: 20596671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies.
    Thellung S; Favoni RE; Würth R; Nizzari M; Pattarozzi A; Daga A; Florio T; Barbieri F
    Curr Drug Targets; 2016; 17(7):824-49. PubMed ID: 26240051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents.
    Pasdar EA; Smits M; Stapelberg M; Bajzikova M; Stantic M; Goodwin J; Yan B; Stursa J; Kovarova J; Sachaphibulkij K; Bezawork-Geleta A; Sobol M; Filimonenko A; Tomasetti M; Zobalova R; Hozak P; Dong LF; Neuzil J
    PLoS One; 2015; 10(5):e0119549. PubMed ID: 25932953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.
    Menges CW; Kadariya Y; Altomare D; Talarchek J; Neumann-Domer E; Wu Y; Xiao GH; Shapiro IM; Kolev VN; Pachter JA; Klein-Szanto AJ; Testa JR
    Cancer Res; 2014 Feb; 74(4):1261-1271. PubMed ID: 24371224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-cadherin expression is correlated with focal adhesion kinase inhibitor resistance in Merlin-negative malignant mesothelioma cells.
    Kato T; Sato T; Yokoi K; Sekido Y
    Oncogene; 2017 Sep; 36(39):5522-5531. PubMed ID: 28553954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells.
    Kim MC; Cui FJ; Kim Y
    Asian Pac J Cancer Prev; 2013; 14(6):3625-30. PubMed ID: 23886156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OCT4&SOX2-specific cytotoxic T lymphocytes plus programmed cell death protein 1 inhibitor presented with synergistic effect on killing lung cancer stem-like cells in vitro and treating drug-resistant lung cancer mice in vivo.
    Zhang X; Hu F; Li C; Zheng X; Zhang B; Wang H; Tao G; Xu J; Zhang Y; Han B
    J Cell Physiol; 2019 May; 234(5):6758-6768. PubMed ID: 30382588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
    Sato T; Sekido Y
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
    Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
    Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma.
    Chiou GY; Cherng JY; Hsu HS; Wang ML; Tsai CM; Lu KH; Chien Y; Hung SC; Chen YW; Wong CI; Tseng LM; Huang PI; Yu CC; Hsu WH; Chiou SH
    J Control Release; 2012 Apr; 159(2):240-50. PubMed ID: 22285547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
    Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
    Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study.
    Fennell DA; Baas P; Taylor P; Nowak AK; Gilligan D; Nakano T; Pachter JA; Weaver DT; Scherpereel A; Pavlakis N; van Meerbeeck JP; Cedrés S; Nolan L; Kindler H; Aerts JGJV
    J Clin Oncol; 2019 Apr; 37(10):790-798. PubMed ID: 30785827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy.
    Deng XB; Xiao L; Wu Y; Jin F; Mossman B; Testa JR; Xiao GH
    Int J Cancer; 2015 Jul; 137(2):481-90. PubMed ID: 25501304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line.
    Blum W; Pecze L; Felley-Bosco E; Worthmüller-Rodriguez J; Wu L; Vrugt B; de Perrot M; Schwaller B
    In Vitro Cell Dev Biol Anim; 2015 Aug; 51(7):714-21. PubMed ID: 25877069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells.
    Zanellato I; Colangelo D; Osella D
    Curr Cancer Drug Targets; 2018; 18(8):816-828. PubMed ID: 28669341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
    Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
    Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.